Papillomatosis Reticulated Konfluen (Confluent reticulated papillomatosis) nyaéta dermatosis ichthyosiform anu jarang tapi khas anu dicirian ku bintik-bintik poék, bersisik, anu biasana dilokalkeun utamana dina batang tengah. Kasakit bisa diubaran ku Minocycline.
Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
Kasus has ― Nembongan salaku titik pigmented hideung tanpa gejala (gatal, nyeri) sabudeureun cangkéng.
Confluent and reticulated papillomatosis (CRP) , disebut oge sindrom Gougerot-Carteaud, hasil tina tumuwuhna sél kulit abnormal. Éta némbongan salaku bintik poék anu henteu aya rasa nyeri anu tiasa ngahijikeun kana patches anu langkung ageung, biasana muncul dina dada luhur sareng beuheung rumaja sareng déwasa ngora. Pilihan terapi awal nyaéta minocycline. Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
CRP biasana muncul salaku bintik poék jeung patch tanpa gejala dina kulit sabudeureun beuheung, kelek, dada luhur, jeung balik luhur. Kadang-kadang, éta tiasa nyebarkeun dugi ka dahi sareng ka handap ka daérah pubic. Antibiotik kawas minocycline geus jadi pilihan perlakuan pikaresep. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ Perlakuan
#Minocycline